Published in J Med Chem on December 04, 2014
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res (2015) 10.66
Small molecules with antiviral activity against the Ebola virus. F1000Res (2015) 0.90
Tales from the war on error: the art and science of curating QSAR data. J Comput Aided Mol Des (2015) 0.75
VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization. BMC Bioinformatics (2017) 0.75
ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model (2005) 16.75
ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res (2011) 14.51
PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res (2009) 11.05
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res (2006) 10.36
New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem (2010) 6.54
The properties of known drugs. 1. Molecular frameworks. J Med Chem (1996) 4.75
The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci Transl Med (2011) 3.80
PubChem as a public resource for drug discovery. Drug Discov Today (2010) 3.40
Evolution of protein fold in the presence of functional constraints. Curr Opin Struct Biol (2006) 2.66
A crowdsourcing evaluation of the NIH chemical probes. Nat Chem Biol (2009) 2.29
UniChem: a unified chemical structure cross-referencing and identifier tracking system. J Cheminform (2013) 2.23
BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results. BMC Bioinformatics (2011) 2.13
Public chemical compound databases. Curr Opin Drug Discov Devel (2008) 1.84
RECAP--retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J Chem Inf Comput Sci (1998) 1.79
A pharmacological organization of G protein-coupled receptors. Nat Methods (2013) 1.65
ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. J Am Chem Soc (2005) 1.48
Internet-based tools for communication and collaboration in chemistry. Drug Discov Today (2008) 1.44
Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery. Drug Discov Today (2009) 1.40
Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17. J Chem Inf Model (2012) 1.39
Towards a gold standard: regarding quality in public domain chemistry databases and approaches to improving the situation. Drug Discov Today (2012) 1.39
InChI in the wild: an assessment of InChIKey searching in Google. J Cheminform (2013) 1.23
A quality alert and call for improved curation of public chemistry databases. Drug Discov Today (2011) 1.22
SciFinder Scholar 2006: an empirical analysis of research topic query processing. J Chem Inf Model (2006) 1.11
Rules for identifying potentially reactive or promiscuous compounds. J Med Chem (2012) 1.11
Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds. J Cheminform (2009) 1.08
Large-scale annotation of small-molecule libraries using public databases. J Chem Inf Model (2007) 1.08
Open source drug discovery - a limited tutorial. Parasitology (2013) 1.06
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates. Drug Discov Today (2012) 1.05
Enhancement of chemical rules for predicting compound reactivity towards protein thiol groups. J Comput Aided Mol Des (2007) 0.99
Elsevier opens its papers to text-mining. Nature (2014) 0.96
An Overview of the Challenges in Designing, Integrating, and Delivering BARD: A Public Chemical-Biology Resource and Query Portal for Multiple Organizations, Locations, and Disciplines. J Biomol Screen (2014) 0.95
One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade. Drug Discov Today (2013) 0.91
Dispensing processes impact apparent biological activity as determined by computational and statistical analyses. PLoS One (2013) 0.88
Extracting and connecting chemical structures from text sources using chemicalize.org. J Cheminform (2013) 0.87
Distant polypharmacology among MLP chemical probes. ACS Chem Biol (2014) 0.84
Computational prediction and validation of an expert's evaluation of chemical probes. J Chem Inf Model (2014) 0.84
Fast and accurate semantic annotation of bioassays exploiting a hybrid of machine learning and user confirmation. PeerJ (2014) 0.82
Openness as infrastructure. J Cheminform (2011) 0.82
Digital chemistry in the Journal of Medicinal Chemistry. J Med Chem (2014) 0.81
InChI: connecting and navigating chemistry. J Cheminform (2012) 0.80
Drug discovery: follow your lead. Nat Chem Biol (2014) 0.77
Public molecules: small, but perfectly formed. Nat Rev Drug Discov (2004) 0.77
Accessing, using, and creating chemical property databases for computational toxicology modeling. Methods Mol Biol (2012) 0.77
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucleic Acids Res (2013) 9.61
Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science (2014) 3.37
Structure Elucidator: a versatile expert system for molecular structure elucidation from 1D and 2D NMR data and molecular fragments. J Chem Inf Comput Sci (2004) 2.19
Towards BioDBcore: a community-defined information specification for biological databases. Nucleic Acids Res (2010) 1.97
Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining. J Cheminform (2010) 1.82
A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett (2005) 1.71
Rapid identification of P-glycoprotein substrates and inhibitors. Drug Metab Dispos (2006) 1.68
Automated structure verification based on a combination of 1D (1)H NMR and 2D (1)H - (13)C HSQC spectra. Magn Reson Chem (2007) 1.63
The Spectral Game: leveraging Open Data and crowdsourcing for education. J Cheminform (2009) 1.49
In silico repositioning of approved drugs for rare and neglected diseases. Drug Discov Today (2011) 1.45
Minimum information about a bioactive entity (MIABE). Nat Rev Drug Discov (2011) 1.44
Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery. Drug Discov Today (2009) 1.40
Towards a gold standard: regarding quality in public domain chemistry databases and approaches to improving the situation. Drug Discov Today (2012) 1.39
Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells. J Med Chem (2008) 1.37
Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data. Drug Discov Today (2011) 1.37
Open Drug Discovery Teams: A Chemistry Mobile App for Collaboration. Mol Inform (2012) 1.32
The ChEMBL database as linked open data. J Cheminform (2013) 1.28
Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter. Mol Pharm (2009) 1.26
Mobile apps for chemistry in the world of drug discovery. Drug Discov Today (2011) 1.26
Towards BioDBcore: a community-defined information specification for biological databases. Database (Oxford) (2011) 1.24
Methods for predicting human drug metabolism. Adv Clin Chem (2007) 1.24
A quality alert and call for improved curation of public chemistry databases. Drug Discov Today (2011) 1.22
Molecular determinants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2. Mol Pharmacol (2005) 1.21
New predictive models for blood-brain barrier permeability of drug-like molecules. Pharm Res (2008) 1.20
The importance of discerning shape in molecular pharmacology. Trends Pharmacol Sci (2009) 1.17
Expression and characterization of the isolated glycosyltransferase module of Escherichia coli PBP1b. Biochemistry (2004) 1.17
A generalizable pre-clinical research approach for orphan disease therapy. Orphanet J Rare Dis (2012) 1.16
Pharmacophore-based discovery of ligands for drug transporters. Adv Drug Deliv Rev (2006) 1.15
The application of 1H high-resolution magic-angle spinning NMR for the study of clay-organic associations in natural and synthetic complexes. Langmuir (2006) 1.14
Identification of "known unknowns" utilizing accurate mass data and ChemSpider. J Am Soc Mass Spectrom (2011) 1.14
Reaching out to collaborators: crowdsourcing for pharmaceutical research. Pharm Res (2010) 1.14
A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine. Drug Metab Dispos (2008) 1.14
Bacterial peptide recognition and immune activation facilitated by human peptide transporter PEPT2. Am J Respir Cell Mol Biol (2008) 1.13
Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine. BMC Emerg Med (2009) 1.12
Novel inhibitors of human organic cation/carnitine transporter (hOCTN2) via computational modeling and in vitro testing. Pharm Res (2009) 1.09
Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development. Lab Chip (2009) 1.09
Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists. Pharm Res (2009) 1.09
Mapping between databases of compounds and protein targets. Methods Mol Biol (2012) 1.09
Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. Mol Pharmacol (2003) 1.08
Evolution of the bile salt nuclear receptor FXR in vertebrates. J Lipid Res (2008) 1.08
Molecular determinants of ligand selectivity for the human multidrug and toxin extruder proteins MATE1 and MATE2-K. J Pharmacol Exp Ther (2012) 1.07
Multifaceted roles of ultra-rare and rare disease patients/parents in drug discovery. Drug Discov Today (2013) 1.07
Ligand specificity and evolution of liver X receptors. J Steroid Biochem Mol Biol (2008) 1.06
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates. Drug Discov Today (2012) 1.05
Chemical target and pathway toxicity mechanisms defined in primary human cell systems. J Pharmacol Toxicol Methods (2009) 1.04
Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties. Drug Metab Dispos (2010) 1.04
Essential metabolites of Mycobacterium tuberculosis and their mimics. MBio (2011) 1.04
Scientific competency questions as the basis for semantically enriched open pharmacological space development. Drug Discov Today (2013) 1.04
Structural revisions of natural products by Computer-Assisted Structure Elucidation (CASE) systems. Nat Prod Rep (2010) 1.04
Time for cooperation in health economics among the modelling community. Pharmacoeconomics (2010) 1.04
Automated structure verification based on 1H NMR prediction. Magn Reson Chem (2006) 1.03
Shape signatures: new descriptors for predicting cardiotoxicity in silico. Chem Res Toxicol (2008) 1.01
Comparative pharmacophore modeling of organic anion transporting polypeptides: a meta-analysis of rat Oatp1a1 and human OATP1B1. J Pharmacol Exp Ther (2005) 1.01
Peroxynitrite mediates active site tyrosine nitration in manganese superoxide dismutase. Evidence of a role for the carbonate radical anion. J Am Chem Soc (2010) 1.00
Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP). Mol Pharm (2013) 0.99
Machine learning methods and docking for predicting human pregnane X receptor activation. Chem Res Toxicol (2008) 0.99
TB Mobile: a mobile app for anti-tuberculosis molecules with known targets. J Cheminform (2013) 0.98
Annotating Human P-Glycoprotein Bioassay Data. Mol Inform (2012) 0.98
PXR and the regulation of apoA1 and HDL-cholesterol in rodents. Pharmacol Res (2004) 0.98
Toward more reliable 13C and 1H chemical shift prediction: a systematic comparison of neural-network and least-squares regression based approaches. J Chem Inf Model (2007) 0.97
Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR. Mol Cell Endocrinol (2010) 0.97
Structural biology and function of solute transporters: implications for identifying and designing substrates. Drug Metab Rev (2002) 0.97
Computational approaches that predict metabolic intermediate complex formation with CYP3A4 (+b5). Drug Metab Dispos (2007) 0.96
The use of unsymmetrical indirect covariance NMR methods to obtain the equivalent of HSQC-NOESY data. Magn Reson Chem (2007) 0.96
Redefining Cheminformatics with Intuitive Collaborative Mobile Apps. Mol Inform (2012) 0.96
Fuzzy structure generation: a new efficient tool for Computer-Aided Structure Elucidation (CASE). J Chem Inf Model (2007) 0.95
Comprehensive computational assessment of ADME properties using mapping techniques. Curr Drug Discov Technol (2005) 0.95
Combining cheminformatics methods and pathway analysis to identify molecules with whole-cell activity against Mycobacterium tuberculosis. Pharm Res (2012) 0.94
Long-range carbon-carbon connectivity via unsymmetrical indirect covariance processing of HSQC and HMBC NMR data. Magn Reson Chem (2006) 0.94
Computational models to assign biopharmaceutics drug disposition classification from molecular structure. Pharm Res (2007) 0.94
Novel yeast-based strategy unveils antagonist binding regions on the nuclear xenobiotic receptor PXR. J Biol Chem (2013) 0.93
Discovery of novel antimalarial compounds enabled by QSAR-based virtual screening. J Chem Inf Model (2013) 0.93
Integrated in silico-in vitro strategy for addressing cytochrome P450 3A4 time-dependent inhibition. Chem Res Toxicol (2010) 0.93
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug Metab Dispos (2010) 0.93
Identification and validation of novel human pregnane X receptor activators among prescribed drugs via ligand-based virtual screening. Drug Metab Dispos (2010) 0.92
Intrinsic disorder in nuclear hormone receptors. J Proteome Res (2008) 0.92
Splice variants: a homology modeling approach. Proteins (2004) 0.92
Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50). J Biomol Screen (2002) 0.91
Pharmacophore modeling of cytochromes P450. Adv Drug Deliv Rev (2002) 0.90
Analysis and elimination of artifacts in indirect covariance NMR spectra via unsymmetrical processing. Magn Reson Chem (2005) 0.90
Quantitative structure activity relationship for inhibition of human organic cation/carnitine transporter. Mol Pharm (2010) 0.90
Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis. Pharm Res (2006) 0.90
Reengineering the pharmaceutical industry by crash-testing molecules. Drug Discov Today (2005) 0.90
Computational models for neglected diseases: gaps and opportunities. Pharm Res (2013) 0.89
Troubleshooting computational methods in drug discovery. J Pharmacol Toxicol Methods (2010) 0.89
When pharmaceutical companies publish large datasets: an abundance of riches or fool's gold? Drug Discov Today (2010) 0.89
The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species. BMC Biochem (2011) 0.89
Bigger data, collaborative tools and the future of predictive drug discovery. J Comput Aided Mol Des (2014) 0.89
Kohonen maps for prediction of binding to human cytochrome P450 3A4. Drug Metab Dispos (2004) 0.88
Finding promiscuous old drugs for new uses. Pharm Res (2011) 0.88
Dispensing processes impact apparent biological activity as determined by computational and statistical analyses. PLoS One (2013) 0.88
Hybrid scoring and classification approaches to predict human pregnane X receptor activators. Pharm Res (2008) 0.88
Looking back to the future: predicting in vivo efficacy of small molecules versus Mycobacterium tuberculosis. J Chem Inf Model (2014) 0.87